Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme I for injection in heart failure after acute ST-segment elevation myocardial infarction
CTR20252331Phase 2Active
- Sponsor
- Hefei Kono Biopharmaceutical
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotinamide adenine dinucleotide in heart failure (HF), sponsored by Hefei Kono Biopharmaceutical. Started Jul 2025; status: active.
02
Drugs
nicotinamide adenine dinucleotide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on CTR20252331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252331.